We are Juno –
an Australian team of innovative thinkers,
passionate about supporting hospitals and
healthcare specialists with industry leading,
off-patent pharmaceuticals.

Company NEWS

Juno Acquires Local Portfolio of Essential Injectable Medicines from AstraZeneca

MELBOURNE, AUSTRALIA – Juno Pharmaceuticals Pty Ltd is pleased to announce the acquisition of a local portfolio of essential injectable medicines from AstraZeneca Pty Ltd.  This acquisition will see Juno’s product range grow to over 60 molecules, focussed mainly in the hospital segment. Read more

Product NEWS

Juno Pharmaceuticals Launches Schedule 3 Naloxone Hydrochloride

Juno Pharmaceuticals is excited to announce the launch of Junalox (naloxone hydrochloride) 400 mcg/1 mL solution for injection, the first product of its type registered as a Schedule 3 - Pharmacist Only Medicine. Read more

Our Products

Know what product you're looking for or need help with your search? Just use the search function below to find it by product name or category.


Partnering with Juno

Working with the right partners is key for us. It means that we can deliver our products as quickly and efficiently as possible to hospitals and healthcare specialists.

For our partners, it’s our competitive edge as a privately owned Australian business, our understanding of the Australian and New Zealand hospital markets, our collaborative outlook and innovative approach that sets us apart.

Learn more